Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sergio Ramos-Cillán
Observed names:
S Ramos Cillan,
S. Ramos Cillan,
S. Ramos Cillán,
SERGIO RAMOS CILLÁN,
Sergio Ramos,
Sergio Ramos Cillán,
Sergio Ramos-Cillan
show all 7
Institutions:
Hospital Universitario Fundación Jiménez Díaz,
Instituto de Investigación Sanitaria Fundación Jiménez Díaz
Observed institutions:
Hospital Universitario Fundación Jiménez Díaz,
Instituto de Investigación Sanitaria Fundación Jiménez Díaz,
Universidad Autónoma de Madrid
ORCID:
0000-0002-1770-7614
Observed ORCID:
0000-0002-1770-7614
OpenAlex ID:
A5046060776
N-Terminal Pro-Brain Natriuretic Peptide Plasma Levels Are Associated with Intermediate-Term Follow-Up Cancer in Coronary Patients
2021
·
José Tuñón
, Ana Pello
, et al.
·
Journal of Clinical Medicine
·
6
PDF
Effects of an Electronic Patient Reported Outcome Measures (e‐PROMs) Program on Symptom Reporting, Use of Healthcare, and Overall Survival in Patients With Lymphoma: A Multicenter Prospective Study
2025
·
Raúl Córdoba
, Marta del Olmo Rodríguez
, et al.
·
eJHaem
·
5
PDF
Skin manifestations uncover underlying Follicular helper T-cell lymphoma, angioimmunoblastic-type in an immunosuppressed patient
2025
·
Marie-Laure García
, Rebeca Manso
, et al.
·
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
·
2
Real-World Evidence of Collecting Quality of Life (QoL) and Symptoms Perception Using the HM-PRO© Tool As a Patient-Reported Outcome Measure (PROM) in Patients with Lymphoma While Receiving Intravenous Chemotherapy
2022
·
Lucía Castilla García
, Sergio Ramos Cillán
, et al.
·
Blood
·
2
Feasibility of Electronic Patient-Reported Outcome (ePRO) Measurement Using PRO-CTCAE® Questionnaire to Improve Quality of Life Assessment and Healthcare Resources Management in Patients with Lymphoma Receiving Intravenous Chemotherapy
2022
·
Sergio Ramos-Cillan
, Natalia Barreras Ruiz
, et al.
·
Blood
·
1
Value of Nt Probnp in the Prediction of Cancer in Patients With Stable Coronary Artery Disease
2019
·
Alvaro Aceña
, Sergio Ramos-Cillan
, et al.
·
Journal of the American College of Cardiology
·
1
PDF
Real-world effectiveness and safety of zanubrutinib in Spanish patients with relapsed/refractory marginal zone lymphoma
2026
·
Fernando Martin-Moro
, Ana Muntañola
, et al.
·
Blood Advances
Real‐world resource utilization, toxicity management, and efficacy outcomes of CD20 × CD3 bispecific antibodies in B‐cell lymphoma: A study from the GELTAMO network
2026
·
Mariana Bastos‐Oreiro
, Gloria Iacoboni
, et al.
·
HemaSphere
Cardiac Surveillance for Anthracycline Cardiotoxicity: Clinical Yield in Low-to-Intermediate Risk Patients
2026
·
Andrea Moreno-Arciniegas
, Sandra Gómez-Talavera
, et al.
·
JACC CardioOncology
6004-10. Caracterización Del Daño Vascular En Supervivientes De Cáncer Tratados Con Antraciclinas: Justificación Y Diseño Del Estudio Patagonia
2025
·
Raquel Frías García-Lago
, Carlos Nicolás Pérez-García
, et al.
·
Revista Española de Cardiología
4CPS-158 Relapsed/refractory multiple myeloma and new therapeutic options: experience in a phase 1 clinical trials unit
2024
·
A Martín Siguero
, C Donoso Rengifo
, et al.
·
European Journal of Hospital Pharmacy
PDF
When the devil is in the details: Similarities and differences between WHO and ICC classifications of AML
2024
·
Sergio Ramos-Cillan
, Daniel Láinez-González
, et al.
·
Leukemia Research
Dihydropyridines and Obesity: Unfavorable Prognostic Factors in Patients With Heart Failure With Preserved Ejection Fraction
2023
·
Jose Antonio Esteban Chapel
, Andrea Camblor Blasco
, et al.
·
Journal of the American College of Cardiology
P079: PROCTCAE as a patient-reported outcome measurement (PROM) questionaire in patients with Hodgkin Lymphoma captures different adverse events profile than those reported by physicians
2022
·
Sergio Ramos-Cillan
, Eva Castillo
, et al.
·
HemaSphere
Real World Data of Patient-reported Outcome Measurement (PROM) Using PRO-CTCAE Tool in a Single Center Study in Older Patients with Lymphoma Undergoing Intravenous Chemotherapy
2022
·
S. Ramos Cillan
, N. Barreras Ruiz
, et al.
·
Journal of Geriatric Oncology
A Prospective, Non-Controlled Study of Quality of Life and Symptoms Perception Using HM-PRO Tool as a Patient-Reported Outcome Measurement (PROM) in Patients with Lymphoma While Receiving Intravenous Chemotherapy
2022
·
L. Castilla García
, S. Ramos Cillán
, et al.
·
Journal of Geriatric Oncology
Arterial thrombosis, the unfairly forgotten actor in COVID-19: a case series
2021
·
SERGIO RAMOS CILLÁN
, LAURA SOLÁN BLANCO
, et al.
·
Research Square
PDF
N-terminal Pro-brain Natriuretic Peptide plasma levels are Associated With a Short-Term Diagnosis of Cancer in Patients with Coronary Artery Disease
2020
·
José Tuñón
, Álvaro Aceña
, et al.
·
Research Square
PDF
Show more works
View as search
Works count:
18
Citation count:
17
H-index:
2
I10-index:
Year
Topic
Type